Cargando…

TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes

Telomere maintenance mechanisms (TMM) are used by cancer cells to avoid apoptosis, 85–90% reactivate telomerase, while 10–15% use the alternative lengthening of telomeres (ALT). Due to anti-telomerase-based treatments, some tumors switch from a telomerase-dependent mechanism to ALT; in fact, the co-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armendáriz-Castillo, Isaac, López-Cortés, Andrés, García-Cárdenas, Jennyfer, Guevara-Ramírez, Patricia, Leone, Paola E., Pérez-Villa, Andy, Yumiceba, Verónica, Zambrano, Ana K., Guerrero, Santiago, Paz-y-Miño, César
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397314/ https://www.ncbi.nlm.nih.gov/pubmed/32708340 http://dx.doi.org/10.3390/genes11070834

Ejemplares similares

Identification of Key Proteins from the Alternative Lengthening of Telomeres-Associated Promyelocytic Leukemia Nuclear Bodies Pathway
por: Armendáriz-Castillo, Isaac, et al.
Publicado: (2022)

Post-transcriptional Regulation of Colorectal Cancer: A Focus on RNA-Binding Proteins
por: García-Cárdenas, Jennyfer M., et al.
Publicado: (2019)

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
por: Yumiceba, Verónica, et al.
Publicado: (2020)

Characterization of Ancestral Origin of Cystic Fibrosis of Patients with New Reported Mutations in CFTR
por: Paz-y-Miño, César, et al.
Publicado: (2020)

A deep analysis using panel-based next-generation sequencing in an Ecuadorian pediatric patient with anaplastic astrocytoma: a case report
por: García-Cárdenas, Jennyfer M., et al.
Publicado: (2020)

Genotoxic and Carcinogenic Potential of Compounds Associated with Electronic Cigarettes: A Systematic Review
por: Armendáriz-Castillo, Isaac, et al.
Publicado: (2019)

Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report
por: López-Cortés, Andrés, et al.
Publicado: (2020)

A quick guide for using Microsoft OneNote as an electronic laboratory notebook
por: Guerrero, Santiago, et al.
Publicado: (2019)

Cytogenetic and genomic analysis of a patient with turner syndrome and t(2;12): a case report
por: Leone, Paola E., et al.
Publicado: (2020)

The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data
por: Zambrano, Ana Karina, et al.
Publicado: (2019)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells
por: Abid, Heba Z., et al.
Publicado: (2020)

Alternative lengthening of telomeres (ALT) in cancer stem cells in vivo
por: Bojovic, Bojana, et al.
Publicado: (2014)

Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells
por: Zhao, Shuang, et al.
Publicado: (2019)

The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT)
por: Sohn, Eric J., et al.
Publicado: (2023)

Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
por: De Vitis, Marco, et al.
Publicado: (2018)

Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs
por: Rosso, Ilaria, et al.
Publicado: (2023)

Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)
por: Kusuma, Frances Karla, et al.
Publicado: (2023)

ALT control, delete: FANCM as an anti-cancer target in Alternative Lengthening of Telomeres
por: O’Rourke, Julienne J, et al.
Publicado: (2019)

MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
por: Buttarelli, Francesca Romana, et al.
Publicado: (2022)

ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeats
por: Frank, Lukas, et al.
Publicado: (2022)

Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT)
por: Sun, Haolu, et al.
Publicado: (2023)

Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
por: Sung, Ji-Yong, et al.
Publicado: (2020)

Ring chromosome 15 – cytogenetics and mapping arrays: a case report and review of the literature
por: Paz-y-Miño, César, et al.
Publicado: (2018)

The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
por: Lu, Robert, et al.
Publicado: (2019)

Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway
por: Toubiana, Shir, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins
por: García-Cárdenas, Jennyfer M., et al.
Publicado: (2022)

Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
por: Lawlor, Rita T., et al.
Publicado: (2019)

Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
por: Lu, Robert, et al.
Publicado: (2019)

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
por: Laroche-Clary, Audrey, et al.
Publicado: (2020)

Telomere clustering drives ALT
por: Min, Jaewon, et al.
Publicado: (2019)

Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies
por: Guerrero, Santiago, et al.
Publicado: (2018)

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023)

Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas
por: García-Cárdenas, Jennyfer M., et al.
Publicado: (2023)

Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis
por: Pérez-Villa, Andy, et al.
Publicado: (2023)

Alternative lengthening of telomeres: remodeling the telomere architecture
por: Conomos, Dimitri, et al.
Publicado: (2013)

Alternative Lengthening of Telomeres and Mediated Telomere Synthesis
por: Hou, Kailong, et al.
Publicado: (2022)

The close interaction between hypoxia-related proteins and metastasis in pancarcinomas
por: López-Cortés, Andrés, et al.
Publicado: (2022)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
por: Sapir, Ester, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_plba8ernv1rod16cm2ss3frb1k